When a person develops a serious issue in the pancreas, it can lead to a buildup of fluid or tissue that becomes trapped. These collections, known as pseudocysts or walled-off necrosis, can cause significant pain and complications. Doctors often use stents—small tubes placed into the area—to help drain this fluid and allow the body to heal. Choosing the right type of stent is vital because different designs offer different levels of success and safety for the patient.
A large review looked at data from over 4,000 patients to compare several types of stents. The researchers compared standard plastic tubes (DPPS) against metal options like bi-flanged metal stents (BFMS), fully covered self-expanding metal stents (FCSEMS), and lumen-apposing metal stents (LAMS). They also looked at a combination of LAMS and DPPS to see which method worked best for draining the fluid while keeping patients safe from complications.
The findings showed that several metal options performed better than standard plastic tubes. Specifically, both LAMS and BFMS had higher success rates in treating these conditions overall. For those with walled-off necrosis, multiple types of metal stents outperformed the basic plastic ones. Additionally, a specific combination—LAMS plus DPPS—was found to be much more effective at lowering infection rates compared to other options like BFMS or FCSEMS.
Safety was also a major factor in the study. For patients where there is a high risk of bleeding, the bi-flanged metal stents (BFMS) were shown to have lower bleeding rates than standard plastic tubes. This suggests that different tools can be chosen based on what a specific patient needs most, whether that is better drainage or a lower risk of infection. It is important to remember that this was a network meta-analysis, which means it combined data from many different studies into one big picture. While the results are helpful for doctors making decisions, they are based on associations rather than a single controlled trial. Because of this, these findings should be used as a guide for clinical choices rather than a definitive rule.
For patients right now, this means that medical teams have several high-performing tools available. Instead of a one-size-fits-all approach, doctors can choose specific metal stents to improve success rates or reduce the risk of infection depending on the patient's unique health profile.
